Ajanta Pharma Limited share price
NSE: AJANTPHARM · ISIN INE031B01049
Key numbers
- Market cap
- ₹ 44,333 Cr
- Current price
- ₹ 3,547.80
- 52-week high / low
- ₹ 3,796 / 2,330
- Stock P/E
- 39.0
- Book value
- ₹ 362.4
- Dividend yield
- 1.80%
- ROCE
- 32.3%
- ROE
- 25.4%
- Debt to equity
- 0.06
- Sales growth (3 yrs)
- 13.4%
- Profit growth (3 yrs)
- 21.6%
- 1-year return
- 39.4%
About Ajanta Pharma Limited
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, eye drops, dry powder suspension, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, gynaecology, nephrology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 1,170 | 1,303 | 1,375 | 1,422 | 1,626 |
| Operating profit | 607 | 724 | 758 | 776 | 917 |
| Net profit | 225 | 255 | 274 | 267 | 334 |
| EPS (₹) | 18.00 | 20.44 | 21.91 | 21.35 | 26.75 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.